Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Digoxin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Click to view available options
Quantity:
300 mg
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Digoxin is one of the digitalis glycosides, extensively utilized for the treatment of congestive heart failure (CHF). It exhibits positive inotropic effects, antiarrhythmic as well as vasoconstrictor actions. It is reported that digoxin and other cardiac glycosides could play important role in the prevention and/or treatment of proliferative diseases like cancer. Featured Industries: Pharmaceutical (small molecule)

Specifications
Specifications
CAS | 20830-75-5 |
Purity Grade Notes | These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. |
Linear Formula | C41H64O14 |
MDL Number | MFCD00003674 |
Synonym | Digoxin; 12 beta-Hydroxydigitoxin |
Type | Certified Reference Material |
Quantity | 300 mg |
Formula Weight | 780.94 |
Grade | Certified Reference Material |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction